On the morning of 15 July 2025, China Medical System Holdings Limited ("CMS" or the "Group") rang the ceremonial bell to mark its official listing on ...

Global Peptide Drug Conjugate Market: Witnessing >300% growth from 2018-2024, this market shows strong expansion potential, reaching a $1.40 billion opportunity. With only 2 approved drugs ...

“It’s kind of a sexy term” for a drug that rarely includes actual coke, says one researcher, but that hasn’t hurt the popularity of pink cocaine.

Wegovy, Novo Nordisk's weight loss drug launched in India, check pricing and dosage Wegovy is a GLP-1 receptor agonist that acts on key areas of the brain involved in appetite regulation and food ...

Danish drugmaker Novo Nordisk has fast-tracked the India launch of its blockbuster anti-obesity drug Wegovy (semaglutide 2.4 mg), introducing the once-weekly injectable treatment at a starting ...

Results for weight-loss drug targeting amylin find similar efficacy across different doses and high rates of side effects, raising questions about which dose Novo will pursue.

Urine drug test (UDT) data can generate timely estimates of overdose deaths, a new study suggests. The study, published in JAMA Network Open by specialty lab Millennium Health and The Ohio State ...

In February 2024, when Boo the Whippet became the first patient in a clinical trial of a life-extending drug for senior dogs, a call was put out for more canines. A milestone was reached in the ...

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable divergence with the recommended dosages of urate-lowering therapies ...

The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults with transthyretin amyloid cardiomyopathy, or ATTR-CM.

The drug has swept across the country and brought a massive wave of overdose deaths in its wake.